Trial intelligence / Profile preview

B-HAPPI: Pramipexole in Bipolar Depression

NCT07664852Phase 3Recruiting

Start
Oct 2026
Primary completion
Dec 2029
Countries
1
01

Overview

A Phase 3 trial of pramipexole in bipolar disorder (BD). Started Oct 2026; status: recruiting.

02

Drugs

pramipexole
03

Conditions

bipolar disorder (BD)

Beyond the preview

Go deeper on NCT07664852.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07664852.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call